TULIFTA
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Mar 2022)
What this means for you
This application is over — abandoned 21 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88578191
- Mark type
- Stylized text
- Filed
- 14 Aug 2019
- Published for opposition
- 24 Dec 2019
- Abandoned
- 21 Mar 2022
- Attorney of record
- Karen A. Webb
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and alleviation of migraine headaches
Owner
- Impel NeuroPharma, Inc., Seattle, WA, US
- Impel NeuroPharma, Inc., Seattle, WA, US
Prosecution history
- 21 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2021 — SOU EXTENSION 3 GRANTED
- 16 Aug 2021 — SOU EXTENSION 3 FILED
- 16 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2021 — SOU EXTENSION 2 GRANTED
- 21 Jan 2021 — SOU EXTENSION 2 FILED
- 21 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2020 — SOU EXTENSION 1 GRANTED
- 30 Jul 2020 — SOU EXTENSION 1 FILED
- 30 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 28 Apr 2020 — CORRECTED NOA E-MAILED